Literature DB >> 12684284

Sildenafil for pulmonary arterial hypertension: exciting, but protection required.

Sanjay Mehta.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684284     DOI: 10.1378/chest.123.4.989

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

2.  Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy.

Authors:  Shin-ya Kawashiri; Yukitaka Ueki; Kaoru Terada; Satoshi Yamasaki; Kiyoshi Aoyagi; Atsushi Kawakami
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

Review 3.  The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension.

Authors:  Meng-Chien Willie Hsieh; Wei-Ting Wang; Jwu-Lai Yeh; Chuang-Yu Lin; Yur-Ren Kuo; Su-Shin Lee; Ming-Feng Hou; Yi-Chia Wu
Journal:  Biomedicines       Date:  2022-06-15

4.  Diagnostic dilemma in a child with congenital heart disease on sildenafil.

Authors:  Syed Ahmed Zaki; Deepak Dadge; Shujaath Asif; Preeti Shanbag
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

5.  NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.

Authors:  Yasushi Kawaguchi; Akiko Tochimoto; Masako Hara; Manabu Kawamoto; Tomoko Sugiura; Yasuhiro Katsumata; Jun Okada; Hirobumi Kondo; Mitsuo Okubo; Naoyuki Kamatani
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 6.  Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course.

Authors:  Fabiana Baldi; Leonello Fuso; Eugenio Arrighi; Salvatore Valente
Journal:  Ther Clin Risk Manag       Date:  2014-10-07       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.